Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery
Key Takeaways
- Bioidentical hormones are chemically identical to those produced by the human body, and the term describes structure rather than safety.
- FDA-approved bioidentical formulations undergo rigorous testing for safety and dosing consistency, while compounded preparations carry higher risks of variability.
- Transdermal estradiol and micronized progesterone show favorable safety profiles in large cohort studies, especially for clotting and breast cancer risk.
- Medically supervised peptide therapies such as Sermorelin and Ipamorelin can complement hormone care when paired with comprehensive lab monitoring.
- Patients seeking personalized hormone or peptide protocols can schedule a consultation with the clinical team at Mirror Plastic Surgery to explore safe, individualized options.
Evidence-Based Options for Natural Estrogen Replacement
FDA-approved bioidentical formulations such as Vivelle-Dot (transdermal estradiol patch), Divigel and Estrogel (estradiol gels), Estrace (estradiol tablets), and Prometrium (micronized progesterone capsules) have completed FDA review for safety, quality, and consistent dosing. ACOG Clinical Consensus No. 6 (2023) recommends FDA-approved menopausal hormone therapies over compounded bioidentical versions for managing menopausal symptoms. The NAMS 2022 Position Statement also addresses both FDA-approved bioidentical formulations and compounded preparations.
Compounded preparations, including estriol, compounded progesterone creams, and hormone pellets, are prepared by state-licensed pharmacies but do not carry FDA approval for safety or efficacy. Concerns with compounded preparations include limited oversight, risk of dosing inconsistencies, potential impurities, and lack of sterility assurance. Compounded options remain appropriate in narrow circumstances, such as when a patient needs a dose or delivery form not commercially available, or has a documented allergy to an ingredient in all FDA-approved formulations.
Transdermal estradiol is associated with a lower risk of venous thromboembolism compared to oral estrogen, because the transdermal route bypasses first-pass liver metabolism. The E3N cohort study following more than 80,000 French women found that combined estrogen and micronized progesterone was not associated with increased breast cancer risk over the first five years. Regimens using synthetic progestins showed a different, less favorable risk profile.
FDA-Approved Bioidentical Hormones, Compounded Preparations, and Peptide Support Compared
The following table compares regulatory oversight, strength of evidence, and supervision needs across three common hormone-related approaches. This side-by-side view helps clarify which options carry the most formal safety review and where closer clinical monitoring becomes especially important.
Reviewed by the FDA for safety, quality, and consistent dosingSupported by rigorous clinical trials in humans and animals plus strict manufacturing oversightRequires a prescription, with repeat lab panels recommended every 6–12 months
| Category | FDA-Approved Bioidentical Hormones | Compounded Bioidentical Preparations | Peptide-Based GH Support (Sermorelin/Ipamorelin) |
|---|---|---|---|
| Regulatory Status | No FDA approval, prepared under Section 503A state-licensed pharmacy oversight | Not FDA-approved for adult use, ipamorelin classified as Category 2 bulk substance (Sept 2023), sermorelin retains a distinct regulatory classification | |
| Evidence Level | Summarized in the 2020 National Academies report on compounded bioidentical hormones | Sermorelin has the longest clinical history among GH-releasing peptides, while human data for ipamorelin remains limited | |
| Supervision Requirements | Requires a prescription, ongoing monitoring via blood or saliva tests, and pellet reinsertion every 3–6 months when used | Requires clinician supervision, thorough health history, and lab testing including GH levels and IGF-1 |
Why Single-Point Blood or Salivary Testing Often Misleads
Hormone secretion is dynamic and sensitive to stress, circadian rhythms, and individual metabolism, so a single snapshot test may not capture a patient’s full clinical picture. Healthy individuals of the same age and sex can have hormone levels that differ by a wide margin, which makes interpretation against standard reference ranges unreliable. TSH levels can vary over a single day, and a normal hormone result does not exclude perimenopause.
Salivary tests are vulnerable to contamination from food, drink, or oral hygiene products. Urine tests measure metabolites rather than active hormone levels. Timing, shipping, and storage issues can produce false positive or false negative results, particularly with at-home kits. Comprehensive panels that cover thyroid markers, liver and kidney function, diabetes markers, and full hormone levels, combined with repeat testing after protocol initiation, provide a more reliable foundation for personalized therapy than any single draw.
Meet Ellie Pranckevicius, FNP-BC, Your Peptide and Hormone Guide
Ellie Pranckevicius, FNP-BC, is the lead practitioner for peptide therapies and non-surgical aesthetics at Mirror Plastic Surgery. She holds a Bachelor’s in Health Science from Boston University, completed an aesthetics licensure program, and earned both her Bachelor’s and Master’s in Nursing from the University of South Florida. Four years in the Neuroscience ICU at Tampa General Hospital gave her a deep grounding in physiology, metabolic health, and recovery, and she now applies that expertise directly to peptide therapy and hormone optimization protocols. Her combination of esthetician training and advanced nursing credentials means she understands both the aesthetic outcomes patients seek and the clinical science required to pursue them safely.
Schedule a consultation with Ellie to discuss whether a medically supervised peptide or hormone protocol fits your goals.
How Ellie Structures Medically Supervised Peptide Therapy
Every new patient begins with a 30–60 minute consultation with Ellie. The session covers a full medical history review, a discussion of health goals, and an assessment of existing lab work. For hormone optimization, weight management, or inflammatory conditions, comprehensive panels that include thyroid, liver, kidney, diabetes markers, and hormone levels are reviewed. When results are unavailable, Ellie orders the necessary labs before designing any protocol.
Ellie then builds a custom peptide protocol based on that data. For natural growth hormone support, clinicians frequently combine Sermorelin and Ipamorelin because the two peptides activate complementary receptor pathways, the GHRH receptor and GHS-R1a, which can produce greater GH release than either agent alone. Sermorelin preserves the body’s own somatostatin feedback mechanism, which reduces the risk of above-normal hormone levels that can occur with direct synthetic HGH administration.
All peptides are sourced from reputable providers with rigorous batch testing for quality, purity, and accurate dosage, which helps reduce dosing and contamination risks. To address concerns quickly if they arise, patients receive 24/7 direct access to Ellie via text for support, refill requests, and questions, along with scheduled telemedicine appointments. This level of access applies whether you visit in person at Mirror Plastic Surgery’s St. Petersburg location or participate remotely from elsewhere in the United States.
Maintenance, Follow-Up, and What Happens When Therapy Stops
Safe personalization of hormone and peptide therapy requires continuous laboratory monitoring rather than one-time assessment, so repeat panels are recommended 6–8 weeks after initiating or adjusting a protocol. Maintenance testing every six to twelve months then helps confirm that dosing remains appropriate over time. Peptide therapy functions as an ongoing regimen rather than a single intervention, and results depend on consistent use.1
If therapy is discontinued, the physiological benefits, including GH stimulation, inflammation reduction, or hormonal support, diminish over time, similar to stopping any active health protocol.1 Patients should enter any peptide or hormone program with a clear understanding of the maintenance commitment required to sustain results. Review your lab history with Ellie to decide whether a maintenance plan fits your long-term wellness priorities.
Risks Linked to Unregulated Online Peptide Sources
The online peptide market presents significant quality-control risks. Without third-party batch testing, there is no reliable way to verify that a product contains the stated compound at the stated concentration. Incorrect dosing in either direction can produce no therapeutic response or, in the presence of undiagnosed contraindications, serious adverse effects. Ipamorelin has never received FDA approval for any indication and has never completed Phase 3 clinical trials required for FDA drug approval, which makes careful sourcing and supervision particularly important. Mirror Plastic Surgery sources peptides exclusively from providers with documented batch testing and offers medically supervised protocols, detailed reconstitution instructions, and ongoing clinical oversight, a standard that unregulated online retailers cannot match.
Frequently Asked Questions
Are bioidentical hormones the same as “natural” hormones?
As noted earlier, the term bioidentical refers to a hormone whose molecular structure matches what the human body produces. Although source materials are often plant-derived from yams or soy, laboratory processing is always required to create the final compound. The bioidentical label alone does not guarantee superior safety or efficacy compared with other hormone formulations.
What is the difference between FDA-approved bioidentical hormones and compounded versions?
FDA-approved bioidentical products such as estradiol patches, gels, and micronized progesterone capsules have undergone clinical trials, standardized manufacturing, and quality controls. Compounded preparations are mixed by state-licensed pharmacies to custom doses or delivery forms but have not completed the FDA approval process. Major medical organizations including ACOG and The Menopause Society recommend FDA-approved formulations as the first-line choice and reserve compounded options for cases where no FDA-approved product meets a patient’s clinical need.
How do Sermorelin and Ipamorelin support hormone optimization?
Sermorelin is a synthetic analogue of growth hormone-releasing hormone that stimulates the pituitary gland to produce GH in a pulsatile, physiologically normal pattern. Ipamorelin is a selective growth hormone secretagogue that activates a complementary receptor pathway without meaningfully elevating cortisol or prolactin. When used together under medical supervision with appropriate lab monitoring, including IGF-1 levels, they may support lean body composition, sleep quality, and energy.1 Neither is FDA-approved for adult use, so clinician oversight and quality-controlled sourcing remain essential.
Why is a single hormone blood test not enough to guide therapy?
Hormone levels fluctuate throughout the day, across the menstrual cycle, and in response to stress and sleep, so a single draw can reflect a transient high or low rather than a true baseline. Comprehensive panels that cover thyroid, liver, kidney, diabetes markers, and hormone levels, then repeat after protocol initiation, provide the data needed to design and adjust a safe, individualized plan. Salivary and at-home urine tests add further variability because of contamination risk and sample handling issues.
What happens if I stop peptide therapy?
Benefits from peptide therapy depend on active use. Discontinuing a growth hormone-releasing peptide protocol leads GH stimulation to return to pre-treatment levels over time.1 Peptides used for inflammation management also stop suppressing the underlying inflammatory process once therapy ends.1 Maintenance protocols and regular follow-up with a supervising clinician represent the standard of care for sustaining outcomes.
Can I access Mirror Plastic Surgery’s peptide services remotely?
Yes. The full process, including consultation, lab review, protocol design, and ongoing support, is available via telemedicine across the United States, including Hawaii and Alaska, in addition to in-person visits at the St. Petersburg, Florida office. Ellie remains available via direct text for 24/7 support throughout the course of therapy.
Conclusion: Choosing a Safe Pathway for Hormones and Peptides
Natural bioidentical hormones exist in well-studied, FDA-approved forms with decades of clinical data. Compounded preparations serve a legitimate but narrow role when standard formulations cannot meet a patient’s specific clinical need. For adults seeking a modern, physiologically grounded pathway to hormone optimization, medically supervised Sermorelin and Ipamorelin peptide therapy, built on comprehensive lab panels, individualized protocols, and ongoing clinical oversight, offers a distinct and evidence-informed option. The most influential variable in any hormone or peptide program is not the marketing label on the product, but the quality of the supervision, the rigor of the testing, and the consistency of the follow-up.
Mirror Plastic Surgery’s concierge model centers on those priorities. Begin your individualized assessment and determine which evidence-based pathway fits your health goals.
1 Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.
